D-0085-2022 Class II Terminated
FDA drug recall D-0085-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Oct 5, 2021 and is designated Class II. Reason for recall: Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10… The recall status is terminated (terminated Feb 16, 2023). Affected quantity: 696 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 10, 2021
- Initiation Date
- Oct 5, 2021
- Termination Date
- Feb 16, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 696 bottles
Product description
Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA NDC 43598-743-05
Reason for recall
Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle
Distribution pattern
Nationwide in the US
Code information
L100208, exp 01/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0085-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026